SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-025370
Filing Date
2020-11-12
Accepted
2020-11-12 16:31:08
Documents
6
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10016834_8k.htm 8-K 22073
2 EXHIBIT 99.1 brhc10016834_ex99-1.htm EX-99.1 122949
3 EXHIBIT 99.2 brhc10016834_ex99-2.htm EX-99.2 13876
4 EXHIBIT 99.3 brhc10016834_ex99-3.htm EX-99.3 15028
5 image0.jpg GRAPHIC 5368
6 image00001.jpg GRAPHIC 3325
  Complete submission text file 0001140361-20-025370.txt   187356
Mailing Address 25B VREELAND ROAD FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 201307226
SIC: 2834 Pharmaceutical Preparations